Lenz, H., Lonardi, S., Elez, E., Jensen, L. H., Cutsem, E. V., Touchefeu, Y., Garcia-Carbonero, R., Tougeron, D., Mendez, G., Schenker, M., Fouchardière, C. D. L., Limon, M. L., Yoshino, T., Li, J., Aubin, F., Cela, E., Li, L., Tam, R., Jin, L., André, T. (2025). Nivolumab (NIVO) plus ipilimumab (IPI) vs chemotherapy (chemo) or NIVO monotherapy for microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Expanded analyses from CheckMate 8HW.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.3501